By targeting insulin-like growth factor 2 receptor (IGF2R), miR-143 impairs insulin signaling in 3T3-L1 preadipocytes, while its inhibition protects mice on an HFD against the development of obesity-associated insulin resistance. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.